No spam - just the good stuff

Subscribe to our newsletter

News

Tissue/Organ

Longevity Escape Velocity within 10 years?

New Buck Institute research is big news for Longevity

New Buck Institute study is treasure trove for longevity research

Benzoxazole compound that extends lifespan in worms also slows bone loss in mice by up to 31% over the course of a year’s treatment.

Gut health shines a light on Longevity

Study linking heart health to brain health could delay dementia

World’s most detailed lung map could boost Longevity

Longevity companies to watch in 2021

LyGenesis’ FDA phase 2a clearance and $11m funding boost

A year in Longevity: progress perspectives

A year in Longevity: different perspectives

AKG shown to prevent age-related bone loss

Found: the missing link in the Longevity ‘supply-chain’

eGenesis progresses xenotransplantation toward type 1 diabetes

Is Longevity actually just Replacing Aging?

Novel pathway to cracking the Alzheimer’s puzzle

Profiling and understanding plasma proteomes could unlock Longevity

Move over, cartography – this is heartography

Stopping neurodegeneration in its tracks with ozone therapy

Longevity research into metabolic diseases is heating up

Reproductive Longevity – taking the geroscience approach

Animal study shows new livers can grow in pig lymph nodes

Mending a broken heart by shielding stem cells

Cancer blood test maker Grail files for Nasdaq IPO

Cartilage regrowth could be Longevity OA gamechanger

Significant organ regeneration study progress for LyGenesis

Morphoceuticals and their role in the future of Longevity

All the way from regenerative research to commercialisation

Hyperbaric oxygen could improve cognitive ability

Skin rejuvenation from novel nano-fat graft technique

Researchers heal human lungs by attaching them to pigs

Hufford interview: “It’s worth pointing out just how remarkable this is.”

Researchers 3D bio-print a working heart pump with real human cells

Find us here ...

Subscribe to our newsletter

© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY

First Longevity Ltd is an appointed representative of Prospect Capital Ltd which is authorised and regulated by the Financial Conduct Authority.
The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.